This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy. The Handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease. The Handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice. Two large sections of the book provide a comprehensive A-Z formulary of cardiac and non-cardiac pharmacological agents with practical and accessible information on the most important pharmacological aspects of these agents and their use in clinical practice. The Handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help. The print edition comes with full access to the online version that will be updated at yearly intervals to keep it up to date.
Section 1: Cardiovascular Disease PreventionSE: Heinz Drexel, Massimo Piepoli and Josep Perk: 1: Robert Zweiker and Sabine Perl: Hypertension 2: Heinz Drexel: Dyslipidaemia 3: Christoph Saly: Metabolic Syndrome and Diabetes 4: Freek Verheugt: Thrombosis Section 2: Ischaemic Heart DiseaseSE: Sven Wassmann and Alexander Niessner: 1: Abhiram Prasad and Claire Raphael: Acute Coronary Syndromes 2: Gaetano Antonio Lanza and Antonio De Vita: Chronic stable angina 3: Peter Ong and Udo Sechtem: Coronary artery spasm and microvascular angina 4: Alexander Lyon, Mark Sweeney, and Elmir Omerovic: Takotsubo Syndrome Section 3: Heart FailureSE: Faiez Zannad and Theresa McDonagh: 1: Faiez Zannad, Joao Pedro Ferreira, and Theresa McDonagh: Heart failure 2: Finn Gustafsson and Kasper Rossing: Heart transplantation Section 4: ArrhythmiasSE: Antoni Martinez-Rubio and Dan Atar: 1: George Dan and Jan Steffel: Atrial fibrillation 2: Julio Marti: Supraventricular (narrow complex) tachycardias 3: Martin Borggrefe, Erol Tulumen, and Josep Brugada: Ventricular arrhythmias 4: Haran Burri: Bradyarrhythmias 5: Ricardo Ruiz-Granell: Syncope Section 5: Structural heart diseaseSE: Claudio Ceconi and Francesca Mantovani: 1: Francesca Mantovani: Valvular Heart Disease 2: Giovanni Boffa and Claudio Ceconi: Myocarditis/ Pericardial Syndromes 3: Giovanni Boffa: Cardiomyopathy 4: James Tonkin, Kate Ryan and Brendan Madden: Pulmonary Hypertension Section 6: Management of cardiovascular disease in pregnancy and lactation and in the presence of co-morbiditiesSE: Debasish Banerjee and David Goldsmith: 1: Debasish Banerjee, Robin Ramphul, and David Goldsmith: Kidney disease 2: Anita Banerjee, Debasish Banerjee, and Vivek Jha: Pregnancy and lactation 3: Nina Hojs, Aftab Ala, and Debasish Banerjee: Liver disease Section 7: Major drug interactionsSE: Birgitte Klindt Poulsen and Ljubica Vukelic Andersen: 1: Maja Hellfritzsch Poulsen and Marlene Lunddal Krogh: Major drug interactions Section 8: Cardiovascular drugs from A to ZSE: Juan Tamargo: 1: Juan Tamargo, Ricardo Caballero and Eva Delpon: Cardiovascular drugs from A to Z Section 9: Non-cardiac drugs affecting the heart - from A to ZSE: Juan Tamargo: 1: Eva Delpon and Juan Tamargo: Non-cardiac drugs affecting the heart